Knott David M Has Decreased Pfizer (PFE) Position By $2.00 Million; Willbros Group Has 2.24 Sentiment

February 19, 2018 - By Vivian Park

Knott David M decreased Pfizer Inc. (PFE) stake by 5.5% reported in 2017Q3 SEC filing. Knott David M sold 57,000 shares as Pfizer Inc. (PFE)’s stock declined 3.45%. The Knott David M holds 978,676 shares with $34.94M value, down from 1.04 million last quarter. Pfizer Inc. now has $216.14B valuation. The stock increased 1.54% or $0.55 during the last trading session, reaching $36.26. About 26.24M shares traded or 24.01% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 19, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Willbros Group, Inc., through its subsidiaries, operates as a specialty energy infrastructure contractor serving gas and oil, and power industries in the United States and Canada. The company has market cap of $61.96 million. The firm operates through three divisions: Oil & Gas, Utility T&D, and Canada. It currently has negative earnings. The Oil & Gas segment offers construction, maintenance, and lifecycle extension services to the midstream markets.

Since August 21, 2017, it had 0 insider purchases, and 7 insider sales for $12.30 million activity. Another trade for 94,409 shares valued at $3.21 million was made by DAMELIO FRANK A on Thursday, August 31. MACKENZIE ALEXANDER R also sold $249,900 worth of Pfizer Inc. (NYSE:PFE) shares. $296,560 worth of Pfizer Inc. (NYSE:PFE) was sold by JOHNSON RADY A on Friday, December 15. OLSON LAURIE J sold 8,064 shares worth $263,693. $1.34M worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY. $6.70 million worth of stock was sold by READ IAN C on Thursday, August 31.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It improved, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Signaturefd Ltd Liability Corporation stated it has 31,880 shares or 0.15% of all its holdings. Princeton Capital Mngmt stated it has 2.51% in Pfizer Inc. (NYSE:PFE). Peloton Wealth Strategists stated it has 1.45% in Pfizer Inc. (NYSE:PFE). Bremer National Association has 39,933 shares. Cwm Limited Liability Company, Nebraska-based fund reported 85,313 shares. 6.46 million are owned by Caisse De Depot Et Placement Du Quebec. Bryn Mawr Trust Co holds 0.57% of its portfolio in Pfizer Inc. (NYSE:PFE) for 282,521 shares. Beddow Management Incorporated holds 216,665 shares or 3.28% of its portfolio. The Michigan-based Aspen Management Inc has invested 0.76% in Pfizer Inc. (NYSE:PFE). Horrell Capital Mngmt holds 159 shares. Avalon Advsr Ltd Llc reported 1.55M shares. Court Place Advisors Limited Liability Corp stated it has 79,341 shares. Cim Invest Mangement Inc accumulated 35,407 shares. Georgia-based Capital Inv Advsr Limited Liability Company has invested 0.67% in Pfizer Inc. (NYSE:PFE). Cranbrook Wealth Management Lc reported 4,994 shares.

Knott David M increased Stemline Therapeutics Inc. (NASDAQ:STML) stake by 33,300 shares to 74,992 valued at $832,000 in 2017Q3. It also upped Global Blood Therapeutics Inc. stake by 11,500 shares and now owns 24,224 shares. Mondelez Int’l Inc. (NASDAQ:MDLZ) was raised too.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, September 5. BMO Capital Markets maintained the shares of PFE in report on Friday, April 28 with “Hold” rating. The rating was maintained by Piper Jaffray with “Overweight” on Saturday, September 5. On Wednesday, October 28 the stock rating was maintained by S&P Research with “Hold”. The rating was maintained by Jefferies on Thursday, July 14 with “Buy”. The stock has “Hold” rating by SunTrust on Monday, October 16. The rating was initiated by Societe Generale with “Hold” on Wednesday, April 6. Argus Research maintained Pfizer Inc. (NYSE:PFE) on Wednesday, July 29 with “Buy” rating. BMO Capital Markets maintained the stock with “Buy” rating in Friday, December 15 report. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Friday, August 28. Piper Jaffray has “Overweight” rating and $48 target.

The stock 0.35% or $0 during the last trading session, reaching $0.98. It is down 22.01% since February 19, 2017 and is downtrending. It has underperformed by 38.71% the S&P500.

Analysts await Willbros Group, Inc. (NYSE:WG) to report earnings on March, 6. They expect $-0.08 EPS, up 57.89% or $0.11 from last year’s $-0.19 per share. After $-0.52 actual EPS reported by Willbros Group, Inc. for the previous quarter, Wall Street now forecasts -84.62% EPS growth.

Gendell Jeffrey L holds 1.28% of its portfolio in Willbros Group, Inc. for 4.95 million shares. Schneider Capital Management Corp owns 2.18 million shares or 1.26% of their US portfolio. Moreover, Heartland Advisors Inc has 0.87% invested in the company for 4.19 million shares. The New York-based Kohlberg Kravis Roberts & Co. L.P. has invested 0.38% in the stock. Prescott Group Capital Management L.L.C., a Oklahoma-based fund reported 206,770 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: